{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:26Z","timestamp":1792425626158,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008312","name":"Fondation Pierre Deniker pour la Recherche et la Pr\u00e9vention en Sant\u00e9 Mentale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["26500"],"award-info":[{"award-number":["26500"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.biopsych.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:14:53Z","timestamp":1566558893000},"page":"514-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Rapid Anxiolytic Effects of RS67333, a Serotonin Type 4 Receptor Agonist, and Diazepam, a Benzodiazepine, Are Mediated by Projections From the Prefrontal Cortex to the Dorsal Raphe Nucleus"],"prefix":"10.1016","volume":"87","author":[{"given":"Charl\u00e8ne","family":"Faye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Hen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Guiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain M.","family":"Gardier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Mendez-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2019.08.009_bib1","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/nn.3262","article-title":"Neurogenesis and generalization: A new approach to stratify and treat anxiety disorders","volume":"15","author":"Kheirbek","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 14","key":"10.1016\/j.biopsych.2019.08.009_bib3","first-page":"27","article-title":"The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam","volume":"63","author":"Klein","year":"2002","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.mp.4001852","article-title":"Treatment-resistant anxiety disorders","volume":"11","author":"Bystritsky","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/npp.2013.332","article-title":"Rapid anxiolytic effects of a 5-HT(4) receptor agonist are mediated by a neurogenesis-independent mechanism","volume":"39","author":"Mendez-David","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.08.009_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1073858414561303","article-title":"Serotonin 1A and serotonin 4 receptors: Essential mediators of the neurogenic and behavioral actions of antidepressants","volume":"22","author":"Samuels","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.biopsych.2019.08.009_bib7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/mp.2017.240","article-title":"CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior","volume":"23","author":"Castello","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/S1461145711000782","article-title":"Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3\u00a0and 7 days) administration of the 5-HT(4) receptor agonist RS67333","volume":"15","author":"Pascual-Brazo","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2019.08.009_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.08.009_bib10","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/13816128113196660734","article-title":"Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?","volume":"20","author":"Vidal","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.biopsych.2019.08.009_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113581","article-title":"Alterations of expression of the serotonin 5-HT4 receptor in brain disorders","volume":"19","author":"Rebholz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2016.08.037","article-title":"The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor","volume":"111","author":"Amigo","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.08.009_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1568007043482615","article-title":"5-HT4 receptors","volume":"3","author":"Bockaert","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.biopsych.2019.08.009_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0028-3908(97)00037-3","article-title":"Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB\u00a0204070A and SB 207266A in rats","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.08.009_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(96)00457-8","article-title":"Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test","volume":"309","author":"Silvestre","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.009_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bjp.0701513","article-title":"The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light\/dark test","volume":"122","author":"Costall","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.009_bib17","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1038\/srep03881","article-title":"Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2\/5-HT3\/5-HT4 ligands","volume":"4","author":"Bell","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2019.08.009_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11011-015-9753-2","article-title":"Behavioral effects of D3 receptor inhibition and 5-HT4 receptor activation on animals undergoing chronic cannabinoid exposure during adolescence","volume":"31","author":"Abboussi","year":"2016","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.biopsych.2019.08.009_bib19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2004.12.023","article-title":"Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: Viral transfections, subacute and chronic treatments with 5-HT4 agonists","volume":"57","author":"Lucas","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-3223(01)01328-2","article-title":"Anxiety and affective style: role of prefrontal cortex and amygdala","volume":"51","author":"Davidson","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnsys.2014.00230","article-title":"Optogenetic dissection of medial prefrontal cortex circuitry","volume":"8","author":"Riga","year":"2014","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature11617","article-title":"A\u00a0prefrontal cortex-brainstem neuronal projection\u00a0that controls response to behavioural challenge","volume":"492","author":"Warden","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.009_bib23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1523\/JNEUROSCI.0092-12.2013","article-title":"Cortical control of affective networks","volume":"33","author":"Kumar","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnbeh.2014.00043","article-title":"Optogenetic modulation of descending prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaffective choices after social defeat","volume":"8","author":"Challis","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1126\/science.aau8722","article-title":"Intense threat switches dorsal raphe serotonin neurons to a paradoxical operational mode","volume":"363","author":"Seo","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.08.009_bib26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.08.009_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20447","article-title":"Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions","volume":"484","author":"Vilaro","year":"2005","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.biopsych.2019.08.009_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.celrep.2017.10.003","article-title":"Adaptive control of dorsal raphe by 5-HT4 in the prefrontal cortex prevents persistent hypophagia following stress","volume":"21","author":"Jean","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2019.08.009_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00429-014-0890-x","article-title":"The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function","volume":"221","author":"Moha ou Maati","year":"2016","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.biopsych.2019.08.009_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/jpet.106.109678","volume":"321","author":"David","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2019.08.009_bib31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/mp.2017.165","article-title":"Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT1A receptor-dependent manner","volume":"23","author":"Garcia-Garcia","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0028-3908(94)90084-1","article-title":"Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain","volume":"33","author":"Waeber","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.08.009_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0033291709005649","article-title":"Neural correlates of worry in generalized anxiety disorder and in normal controls: A functional MRI study","volume":"40","author":"Paulesu","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2019.08.009_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12888-016-0917-3","article-title":"Cortical functional activity in patients with generalized anxiety disorder","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neuron.2014.06.024","article-title":"Presynaptic partners of dorsal raphe serotonergic and GABAergic neurons","volume":"83","author":"Weissbourd","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.08.009_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-8993(99)01208-1","article-title":"Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor","volume":"826","author":"Grahn","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2019.08.009_bib37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/138945009789735200","article-title":"Serotonin receptors, type 4: A new hope?","volume":"10","author":"Lucas","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.biopsych.2019.08.009_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1460-9568.2006.04943.x","article-title":"Adaptive changes in serotonin neurons of the raphe nuclei\u00a0in 5-HT(4) receptor knock-out mouse","volume":"24","author":"Conductier","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/npy.11.9","article-title":"Connection re-established: neurotransmission between the medial prefrontal cortex and serotonergic neurons o ers perspectives for fast antidepressant action","volume":"1","author":"Eti\u00e9vant","year":"2011","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib40","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1476-5381.1996.tb15309.x","article-title":"5-HT4 receptor-mediated modulation of 5-HT\u00a0release in the rat hippocampus in vivo","volume":"117","author":"Ge","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.009_bib41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1460-9568.2002.02150.x","article-title":"5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphe nucleus 5-HT neuronal activity","volume":"16","author":"Lucas","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib42","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00213-016-4327-5","article-title":"Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression","volume":"233","author":"du Jardin","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2019.08.009_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biopsych.2013.12.009","article-title":"Antidepressant-like effects of cortical deep brain stimulation coincide with pro-neuroplastic adaptations of serotonin systems","volume":"76","author":"Veerakumar","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.08.009_bib44","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1523\/JNEUROSCI.1731-10.2010","article-title":"Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex","volume":"30","author":"Covington","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/acn.12016","article-title":"Activation of GABAA receptors in the medial prefrontal cortex produces an anxiolytic-like response","volume":"25","author":"Solati","year":"2013","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.biopsych.2019.08.009_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2016.01.011","article-title":"Direct ventral hippocampal-prefrontal input is required for anxiety-related neural activity and behavior","volume":"89","author":"Padilla-Coreano","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.08.009_bib47","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1523\/JNEUROSCI.1787-13.2014","article-title":"Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: Role of DeltaFosB","volume":"34","author":"Vialou","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.08.009_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neuron.2013.06.016","article-title":"BLA to vHPC inputs modulate anxiety-related behaviors","volume":"79","author":"Felix-Ortiz","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.08.009_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2013.12.007","article-title":"Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice","volume":"261","author":"Chegini","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2019.08.009_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1101\/lm.67303","article-title":"Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat","volume":"10","author":"Orsetti","year":"2003","journal-title":"Learn Mem"},{"key":"10.1016\/j.biopsych.2019.08.009_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2014.12.019","article-title":"The effects of CA1 5HT4 receptors in MK801-induced amnesia and hyperlocomotion","volume":"587","author":"Nasehi","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.08.009_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000090309","article-title":"Drugs acting on serotonin receptors for the treatment of functional GI disorders","volume":"24","author":"Tonini","year":"2006","journal-title":"Dig Dis"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231931621X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231931621X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:55:42Z","timestamp":1777395342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632231931621X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S000632231931621X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.08.009","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Anxiolytic Effects of RS67333, a Serotonin Type 4 Receptor Agonist, and Diazepam, a Benzodiazepine, Are Mediated by Projections From the Prefrontal Cortex to the Dorsal Raphe Nucleus","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}